Astrana Health Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $3.8B+88.9% YoYTTM through 30 Jun 2026
Net Income $40.5M-6.0% YoYTTM through 30 Jun 2026
Free Cash Flow $94.4MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 10.7% |
| EBITDA Margin | 4.3% |
| Operating Margin | 2.5% |
| Net Margin | 1.1% |
Returns
5.7%ROE
1.0%ROA
3.0%ROIC
Balance Sheet Health
Debt / Equity1.33x
Current Ratio1.40x
Net Debt$648.7M
Cash & Equivalents$400.8M
Quality Metrics
Altman Z-Score2.75
Piotroski F-Score5 / 9
FCF Margin2.5%
Rule of 406.1
Earnings-Beat Rate100.0%
Multi-Year Trend
RevenueFY2025: $3.2B
Diluted EPS$0.82TTMFY2025: $0.46
Dividend
No dividend
Capital Allocation
Capex Intensity0.4%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Care Partners | $3B | +55.1% | |
| Care Delivery | $250.7M | +83.5% | |
| Care Enablement |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.